Skip to content

MRI features and imaging-pathology correlation of oligodendroglioma with IDH mutation and 1p/19q codeletion.

Sep 2026 · Clinical Neuropathology · 0 citations
Medicine

Abstract

Objective

To characterize routine magnetic resonance imaging (MRI) manifestations of molecularly defined isocitrate dehydrogenase (IDH)-mutant, 1p/19q codeleted oligodendroglioma, to introduce two newly proposed intratumoral imaging signs, assess their diagnostic efficacy, and interpret their histologic basis via voxel-wise imaging-pathology matching.

Materials And Methods

36 surgically validated oligodendrogliomas were retrospectively analyzed per the 2021 WHO CNS tumor criteria; MRI signals were correlated with histologic indices such as cellular density and myxoid microcystic change.

Results

The cohort comprised 24 males and 12 females with a mean age of (30.9 ± 16.1) years. All supratentorial lesions were mostly cystic-solid, showing T1-hypointense solid parts, T2/fluid-attenuated inversion recovery (FLAIR) slightly hyperintense parenchyma, T2-hyperintense cysts, and heterogeneous enhancement, predominantly WHO grade 2. No intergrade differences in baseline MRI/clinical features were found (p > 0.05). Cross-sectional prevalence: isolated ripple sign 16.7%, isolated finger-like cystic sign 8.3%, dual signs 5.6%, total positivity 30.6%. Separate κ values (0.81 and 0.83) revealed excellent inter-rater consistency; the two signs occurred independently (p > 0.05) with high specificity but low sensitivity. Histologically, the ripple sign stemmed from alternating hypercellular and microcystic grey-white matter bands, whereas finger-like cysts arose from tract-aligned fused microcysts.

Conclusion

This glioma entity mostly presents as infiltrative supratentorial cystic-solid masses. The two novel signs serve as high-specificity auxiliary markers but lack sufficient sensitivity; large multi-center validation is warranted. Integrated MRI and pathological correlation elevate preoperative diagnostic accuracy.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.